Explore All 557 Venture Life Science Deals - Search the Database Free
Investment Summary |
|
|---|---|
| Date | November 30, 2021 |
| Target | HotSpot Therapeutics |
| Sector | Life Science |
| Investor(s) | EQT Life Sciences |
| Deal Type | Venture |
FILTER BY
| Category | Growth Capital Firm |
|---|---|
| Founded | 1987 |
| PE ASSETS | 3.5B EUR |
| Size | Large |
| Type | Sector Focused |
EQT Life Sciences (formerly Life Science Partners) is a private investment firm focused on growth and venture capital financing for life sciences and healthcare companies. The Firm targets early to mid?stage companies in sectors such as therapeutics, medical devices, diagnostics, healthtech, and biotech. EQT Life Sciences was formed in 1986 and is headquartered in Amsterdam, the Netherlands.
| Deal Context for Investor | # |
|---|---|
| Overall | 43 of 47 |
| Sector: Life Science | 27 of 30 |
| Type: Venture | 37 of 39 |
| State: Massachusetts | 3 of 3 |
| Country: United States | 11 of 11 |
| Year: 2021 | 11 of 12 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-10-22 |
Egle
Paris, France Egle is a biotechnology company focused on developing first in class T-regulatory cell therapies based on Treg-starvers for oncology and autoimmune diseases. Egle was founded in 2020 and is based in Paris, France. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-08 |
AviadoBio
London, United Kingdom AviadoBio is a pioneering gene therapy company focused on developing and delivering transformative medicines for people living with neurodegenerative disorders. AviadoBio was founded in 2019 and is based in London, United Kingdom, |
Buy | - |
